-
EP0733072
European procedure
Extract from the Register of European Patents
EP About this file: EP0733072
| EP0733072 - ANTIBODY AGAINST CARCINOEMBRYONIC ANTIGEN (CEA) [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 02.02.2001 Database last updated on 20.05.2024 | Most recent event Tooltip | 02.02.2001 | No opposition filed within time limit | published on 21.03.2001 [2001/12] | Applicant(s) | For all designated states CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED Cambridge House 6-10 Cambridge Terrace Regent's Park London NW1 4JL / GB | [N/P] |
| Former [1996/39] | For all designated states CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED Cambridge House 6-10 Cambridge Terrace Regent's Park London NW1 4JL / GB | Inventor(s) | 01 /
CHESTER, Kerry, Anne CRC Laboratories Royal Free Hospital School of Medicine London NW3 2PF / GB | 02 /
HAWKINS, Robert, Edward Dept. of Clinical Oncology and MRC Centre Hills Road Cambridge CB2 2QH / GB | 03 /
BEGENT, Richard, Henry, John CRC Laboratories Royal Free Hospital School of Medicine London NW3 2PF / GB | [1996/39] | Representative(s) | Goldin, Douglas Michael J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5JJ / GB | [N/P] |
| Former [1997/09] | Goldin, Douglas Michael J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5LX / GB | ||
| Former [1996/39] | Brasnett, Adrian Hugh J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5LX / GB | Application number, filing date | 95902853.1 | 05.12.1994 | [1996/39] | WO1994GB02658 | Priority number, date | GB19930024807 | 03.12.1993 Original published format: GB 9324807 | [1996/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9515341 | Date: | 08.06.1995 | Language: | EN | [1995/24] | Type: | A1 Application with search report | No.: | EP0733072 | Date: | 25.09.1996 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.06.1995 takes the place of the publication of the European patent application. | [1996/39] | Type: | B1 Patent specification | No.: | EP0733072 | Date: | 05.04.2000 | Language: | EN | [2000/14] | Search report(s) | International search report - published on: | EP | 08.06.1995 | Classification | IPC: | C07K16/30, A61K39/395, A61K47/48, A61K51/10, C07K16/00, C12N15/13, C12N15/63 | [1996/39] | CPC: |
B82Y5/00 (EP,US);
A61K47/6899 (EP,US);
A61K47/6853 (EP,US);
A61K51/1048 (EP,US);
A61P35/00 (EP);
C07K16/00 (EP,US);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1996/39] | Title | German: | ANTIKÖRPER GEGEN DAS CARCINOEMBRYONIC ANTIGEN | [1996/39] | English: | ANTIBODY AGAINST CARCINOEMBRYONIC ANTIGEN (CEA) | [1996/39] | French: | ANTICORPS DIRIGE CONTRE L'ANTIGENE CARCINO-EMBRYONNAIRE (CEA) | [1996/39] | Entry into regional phase | 18.06.1996 | National basic fee paid | 18.06.1996 | Designation fee(s) paid | 18.06.1996 | Examination fee paid | Examination procedure | 26.06.1995 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 18.06.1996 | Examination requested [1996/39] | 24.11.1998 | Despatch of communication of intention to grant (Approval: Yes) | 07.06.1999 | Communication of intention to grant the patent | 01.09.1999 | Fee for grant paid | 01.09.1999 | Fee for publishing/printing paid | Opposition(s) | 06.01.2001 | No opposition filed within time limit [2001/12] | Fees paid | Renewal fee | 11.12.1996 | Renewal fee patent year 03 | 12.12.1997 | Renewal fee patent year 04 | 11.12.1998 | Renewal fee patent year 05 | 09.12.1999 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO8807378 (CANCER RES CAMPAIGN TECH [GB]) [A] 17-20 * the whole document *; | [A]EP0396387 (RES DEV FOUNDATION [US]) [A] 17-20 * the whole document *; | [X]WO9101990 (HOPE CITY [US]) [X] 1,2,12,22-24,27-30,36,37 * page 17 - page 19 *; | [A]WO9201059 (CELLTECH LTD [GB]) [A] 1-37 * the whole document *; | [A]EP0497585 (ANDERSON LESLIE DERIEMER [US], et al) [A] 16,33-35 * the whole document *; | [A]EP0501215 (BEHRINGWERKE AG [DE]) [A] 1-10,17,18 * the whole document *; | [A]WO9215333 (AKZO NV [NL], et al) [A] 13-15 * the whole document *; | [A]WO9303151 (MEDICAL RES COUNCIL [GB]) [A] 1-37* the whole document *; | [XP]EP0590530 (BEHRINGWERKE AG [DE]) [XP] 1,2,7-13,17,18,22-30,36,37 * page 2, line 33 - line 53 * * page 4, line 36 - line 38 * * table 1 *; | [XP]WO9419466 (DOW CHEMICAL CO [US], et al) [XP] 1,2,7-13,17,21-24,27-30,36,37 * page 1 - page 4 * * page 6 - page 15 * * page 50 - page 52 * | [XD] - MARIUS NAP ET AL, "Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen", CANCER RESEARCH, PHILADELPHIA, (1992), vol. 52, pages 2329 - 2339 [XD] 1,2,12,36,37 * table 3 * | [AD] - CLACKSON T. ET AL, "Making antibody fragments using phage display libraries", NATURE., LONDON GB, (1991), vol. 352, pages 624 - 628 [AD] 12,31,32 * the whole document * |